Dissertations build on multiple disciplinary perspectives with new contributions to global health knowledge and practice. Lauren Zalla’s project, guided by infectious disease professors Ada Adimora, MD, MPH, and Joe Eron, MD, is a good example. Bringing clinical expertise to Zalla’s dissertation committee, they helped her design a study that explored racial disparities in the prescription … Continued

David J. Weber, MD, MPH, has been appointed to the Healthcare Infection Control Practices Advisory Committee (HICPAC). As a member, Dr. Weber will provide advice and guidance to the Department of Health and Human Services (DHHS) and the Centers for Disease Control and Prevention (CDC). A total of 14 non-federal employee voting members contribute their expertise on … Continued

  “I’ve always felt fortunate that I encountered Paul Farmer and Jim Kim at a time when I wasn’t happy with the way the world looked. At 24, I had no idea what an alternative vision could be. Paul and Jim were able to articulate a more humane and just vision, for which I’ve always … Continued

Magdalene Assimon, PharmD, PhD, Jennifer E. Flythe, MD, MPH, and David Weber, MD received the 2022 Drug Therapy Research Award from the American Society of Health System Pharmacists (ASHP) Foundation for their JAMA Cardiology manuscript titled “Analysis of respiratory fluoroquinolones and the risk of sudden cardiac death among patients receiving hemodialysis.” This award recognizes exceptional … Continued

VISION Study We have learned much about COVID-19 but there are still important questions to be answered about who is at risk for infection, how well vaccines and treatments work over time, and Long COVID, among others. That is why we designed the VISION Study. What Is the VISION Study? VISION is a new study … Continued

The National Institute of Allergy and Infectious Diseases (NIAID) has awarded Arlene Seña, MD, MPH, a member of the Institute for Global Health & Infectious Diseases and professor of infectious diseases, $1.9 million to initiate a longitudinal clinical study over 16 months that will advance diagnostic product development for syphilis, with the potential for additional … Continued

Alpha-Gal Syndrome, or AGS, is a recently identified tick-borne disease that triggers an allergy to red meat and other products made from mammals, including cheese, gelatin, and medications like heparin. Since its discovery in 2009, cases in the United States alone have risen from 24 to >40,000 people, owing to the geographic spread of the … Continued

Since the start of the pandemic, people in jail have faced an inequitably high risk of SARS-CoV-2 infection. Overcrowding and lack of hygiene supplies have left jail populations particularly vulnerable to outbreaks, while frequent population turnover has made it difficult to prevent and track the spread of new variants. In addition, racial incarceration disparities and … Continued

Social workers promote individual and community wellbeing, supporting people through some of life’s most difficult challenges, and this includes Emily Duberman, LCSW, CHES, the Ryan White Lead Social Worker at the UNC Eastowne Infectious Diseases Clinic. Read how Emily came to work in infectious diseases and what she finds particularly gratifying about her work with patients. … Continued

Ross Boyce, MD, MSc, assistant professor in the Division of Infectious Diseases and Department of Epidemiology, has been selected as one of the recipients of the Jefferson-Pilot Fellowships in Academic Medicine. This award is given to exceptional UNC School of Medicine (SOM) junior faculty. “I am honored to receive this award,” said Dr. Boyce. “I … Continued

Global health research is a collaborative process, and each researcher at the Institute for Global Health & Infectious Diseases contributes a piece to solving the puzzle of disease and morbidity. With a new academic year underway, read what some of our investigators are working on to improve the health of global populations. Their multi-disciplinary findings will be … Continued

Led by Martina Kovarova, PhD, Miriam Braunstein, PhD, and J. Victor Garcia, PhD, UNC School of Medicine researchers showed in vivo efficacy of a long-acting injectable formulation of the anti-TB drug rifabutin. Read more.